MAG and neuropathy: Further mechanistic investigations have shown that patients with anti-MAG neuropathy harbor substantial clonal expansions of IgM memory B cells that recognize MAG, while patients who do not experience clinical improvement after rituximab have higher numbers of clonal anti-MAG memory B cells before and after therapy and lower somatic hypermutation frequencies of IgM memory B cells [179].